Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§.

Macholl S, Finucane CM, Hesterman J, Mather SJ, Pauplis R, Scully D, Sosabowski JK, Jouannot E.

EJNMMI Res. 2017 Dec;7(1):33. doi: 10.1186/s13550-017-0281-4. Epub 2017 Apr 7.

2.

Preclinical in vivo cancer, straightway to patients?

de Jong M, Mather S, Maina T.

Q J Nucl Med Mol Imaging. 2017 Jun;61(2):145-152. doi: 10.23736/S1824-4785.17.02974-0. Review.

PMID:
28347131
3.

The first RCGP Global Health Conference: the global impact of family medicine.

Withnall R, Ansari R, Mather S, Wass V.

Br J Gen Pract. 2015 Oct;65(639):534-5. doi: 10.3399/bjgp15X687013. No abstract available.

4.

The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination.

Bentley EM, Mather ST, Temperton NJ.

Vaccine. 2015 Jun 12;33(26):2955-62. doi: 10.1016/j.vaccine.2015.04.071. Epub 2015 Apr 30.

PMID:
25936665
5.

Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models.

Pujatti PB, Foster JM, Finucane C, Hudson CD, Burnet JC, Pasqualoto KFM, Mengatti J, Mather SJ, de Araújo EB, Sosabowski JK.

Appl Radiat Isot. 2015 Feb;96:91-101. doi: 10.1016/j.apradiso.2014.11.006. Epub 2014 Nov 11.

PMID:
25479439
6.

Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging.

Goldstein R, Sosabowski J, Livanos M, Leyton J, Vigor K, Bhavsar G, Nagy-Davidescu G, Rashid M, Miranda E, Yeung J, Tolner B, Plückthun A, Mather S, Meyer T, Chester K.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):288-301. doi: 10.1007/s00259-014-2940-2. Epub 2014 Nov 13.

7.

Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid.

Parente-Pereira AC, Shmeeda H, Whilding LM, Zambirinis CP, Foster J, van der Stegen SJ, Beatson R, Zabinski T, Brewig N, Sosabowski JK, Mather S, Ghaem-Maghami S, Gabizon A, Maher J.

J Immunol. 2014 Dec 1;193(11):5557-66. doi: 10.4049/jimmunol.1402200. Epub 2014 Oct 22.

8.

Lyophilisation of influenza, rabies and Marburg lentiviral pseudotype viruses for the development and distribution of a neutralisation -assay-based diagnostic kit.

Mather ST, Wright E, Scott SD, Temperton NJ.

J Virol Methods. 2014 Dec 15;210:51-8. doi: 10.1016/j.jviromet.2014.09.021. Epub 2014 Oct 5.

PMID:
25286181
9.

The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo.

Wang JT, Fabbro C, Venturelli E, Ménard-Moyon C, Chaloin O, Da Ros T, Methven L, Nunes A, Sosabowski JK, Mather SJ, Robinson MK, Amadou J, Prato M, Bianco A, Kostarelos K, Al-Jamal KT.

Biomaterials. 2014 Nov;35(35):9517-28. doi: 10.1016/j.biomaterials.2014.07.054. Epub 2014 Aug 29.

PMID:
25168822
10.

PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.

Roosenburg S, Laverman P, Joosten L, Cooper MS, Kolenc-Peitl PK, Foster JM, Hudson C, Leyton J, Burnet J, Oyen WJ, Blower PJ, Mather SJ, Boerman OC, Sosabowski JK.

Mol Pharm. 2014 Nov 3;11(11):3930-7. doi: 10.1021/mp500283k. Epub 2014 Jul 11.

PMID:
24992368
11.

GRP receptor imaging of prostate cancer using [(99m)Tc]Demobesin 4: a first-in-man study.

Mather SJ, Nock BA, Maina T, Gibson V, Ellison D, Murray I, Sobnack R, Colebrook S, Wan S, Halberrt G, Szysko T, Powles T, Avril N.

Mol Imaging Biol. 2014 Dec;16(6):888-95. doi: 10.1007/s11307-014-0754-z.

PMID:
24915934
12.

Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma.

Hudson CD, Hagemann T, Mather SJ, Avril N.

Cell Death Dis. 2014 Apr 10;5:e1160. doi: 10.1038/cddis.2014.125.

13.

Magnetically Decorated Multi-Walled Carbon Nanotubes as Dual MRI and SPECT Contrast Agents.

Wang JT, Cabana L, Bourgognon M, Kafa H, Protti A, Venner K, Shah AM, Sosabowski J, Mather SJ, Roig A, Ke X, Tendeloo GV, de Rosales RTM, Tobias G, Al-Jamal KT.

Adv Funct Mater. 2014 Apr 2;24(13):1880-1894. doi: 10.1002/adfm.201302892.

14.

Identification of ZDHHC14 as a novel human tumour suppressor gene.

Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljević N, Chaplin T, Xue L, Xu M, Foster JM, Karnam SS, James SY, Chioni AM, Gould D, Lorincz AT, Oliver RT, Chelala C, Thomas GM, Shipley JM, Mather SJ, Berney DM, Young BD, Lu YJ.

J Pathol. 2014 Apr;232(5):566-77. doi: 10.1002/path.4327. Epub 2014 Feb 8. Erratum in: J Pathol. 2014 Sep;234(1):134.

PMID:
24407904
15.

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.

Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E.

Vaccines (Basel). 2014 Oct 13;2(4):707-34. doi: 10.3390/vaccines2040707. Review.

16.

Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.

Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M, Syed N, Lo Nigro C, Lattanzio L, Chmielewska-Kassassir M, Tomlinson I, Roylance R, Whitaker HC, Warren AY, Neal D, Frezza C, Beltran L, Jones LJ, Chelala C, Wu BW, Bomalaski JS, Jackson RC, Lu YJ, Crook T, Lemoine NR, Mather S, Foster J, Sosabowski J, Avril N, Li CF, Szlosarek PW.

Cancer Res. 2014 Feb 1;74(3):896-907. doi: 10.1158/0008-5472.CAN-13-1702. Epub 2013 Nov 27.

17.

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?

van der Stegen SJ, Davies DM, Wilkie S, Foster J, Sosabowski JK, Burnet J, Whilding LM, Petrovic RM, Ghaem-Maghami S, Mather S, Jeannon JP, Parente-Pereira AC, Maher J.

J Immunol. 2013 Nov 1;191(9):4589-98. doi: 10.4049/jimmunol.1301523. Epub 2013 Sep 23.

18.

Generation and characterization of a diabody targeting the αvβ6 integrin.

Kogelberg H, Miranda E, Burnet J, Ellison D, Tolner B, Foster J, Picón C, Thomas GJ, Meyer T, Marshall JF, Mather SJ, Chester K.

PLoS One. 2013 Sep 4;8(9):e73260. doi: 10.1371/journal.pone.0073260. eCollection 2013.

19.

Structural guided scaffold phage display libraries as a source of bio-therapeutics.

Man YK, DiCara D, Chan N, Vessillier S, Mather SJ, Rowe ML, Howard MJ, Marshall JF, Nissim A.

PLoS One. 2013 Aug 9;8(8):e70452. doi: 10.1371/journal.pone.0070452. eCollection 2013.

20.

Novel indium-111 labeled gastrin peptide analogues (MG-CL1-4): synthesis and quality control.

Naqvi SA, Khan ZA, Nagra SA, Yar M, Sherazi TA, Shahzad SS, Shah SQ, Mahmood N, Ishfaq MM, Mather SJ.

Pak J Pharm Sci. 2013 Mar;26(2):299-305.

PMID:
23455200
21.

International primary care and the RCGP: the college's role in global health.

Wass V, Mather S.

Br J Gen Pract. 2012 Oct;62(603):510-1. doi: 10.3399/bjgp12X654812. No abstract available.

22.

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide.

Wythe SE, DiCara D, Taher TE, Finucane CM, Jones R, Bombardieri M, Man YK, Nissim A, Mather SJ, Chernajovsky Y, Pitzalis C.

Ann Rheum Dis. 2013 Jan;72(1):129-35. doi: 10.1136/annrheumdis-2012-201457. Epub 2012 Jul 27.

23.

Contrasting effects of sunitinib within in vivo models of metastasis.

Welti JC, Powles T, Foo S, Gourlaouen M, Preece N, Foster J, Frentzas S, Bird D, Sharpe K, van Weverwijk A, Robertson D, Soffe J, Erler JT, Pili R, Springer CJ, Mather SJ, Reynolds AR.

Angiogenesis. 2012 Dec;15(4):623-41. doi: 10.1007/s10456-012-9291-z. Epub 2012 Jul 28.

24.

Pathogen identification by nuclear imaging--almost there?

Agrawal SG, Mather SJ.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1173-4. doi: 10.1007/s00259-012-2165-1. No abstract available.

PMID:
22652983
25.

Degree of chemical functionalization of carbon nanotubes determines tissue distribution and excretion profile.

Al-Jamal KT, Nunes A, Methven L, Ali-Boucetta H, Li S, Toma FM, Herrero MA, Al-Jamal WT, ten Eikelder HM, Foster J, Mather S, Prato M, Bianco A, Kostarelos K.

Angew Chem Int Ed Engl. 2012 Jun 25;51(26):6389-93. doi: 10.1002/anie.201201991. Epub 2012 May 23.

PMID:
22623333
26.

Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells.

Davies DM, Foster J, Van Der Stegen SJ, Parente-Pereira AC, Chiapero-Stanke L, Delinassios GJ, Burbridge SE, Kao V, Liu Z, Bosshard-Carter L, Van Schalkwyk MC, Box C, Eccles SA, Mather SJ, Wilkie S, Maher J.

Mol Med. 2012 May 9;18:565-76. doi: 10.2119/molmed.2011.00493.

27.

Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis.

Kamperidis P, Kamalati T, Ferrari M, Jones M, Garrood T, Smith MD, Diez-Posada S, Hughes C, Finucane C, Mather S, Nissim A, George AJ, Pitzalis C.

Arthritis Rheum. 2011 Dec;63(12):3758-67. doi: 10.1002/art.30650.

28.

Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura.

Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, Byrne F, Prina-Mello A, Volkov Y, Li S, Mather SJ, Bianco A, Prato M, Macnee W, Wallace WA, Kostarelos K, Donaldson K.

Am J Pathol. 2011 Jun;178(6):2587-600. doi: 10.1016/j.ajpath.2011.02.040.

29.

Quantitative Accuracy of Low-Count SPECT Imaging in Phantom and In Vivo Mouse Studies.

Finucane CM, Murray I, Sosabowski JK, Foster JM, Mather SJ.

Int J Mol Imaging. 2011;2011:197381. doi: 10.1155/2011/197381. Epub 2011 Mar 16.

30.

Bioluminescence imaging of the brain response to acute inflammation in living C/EBP reporter mice.

Lopez de Heredia L, Gengatharan A, Foster J, Mather S, Magoulas C.

Neurosci Lett. 2011 Jun 22;497(2):134-8. doi: 10.1016/j.neulet.2011.04.046. Epub 2011 Apr 27.

PMID:
21545825
31.

Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice.

Parente-Pereira AC, Burnet J, Ellison D, Foster J, Davies DM, van der Stegen S, Burbridge S, Chiapero-Stanke L, Wilkie S, Mather S, Maher J.

J Clin Immunol. 2011 Aug;31(4):710-8. doi: 10.1007/s10875-011-9532-8. Epub 2011 Apr 20.

PMID:
21505816
32.

Skin disinfection before spinal anaesthesia for caesarean section: a survey of UK practice.

Bradbury CL, Hale B, Mather S, Suri I.

Int J Obstet Anesth. 2011 Jan;20(1):101-2. doi: 10.1016/j.ijoa.2010.07.017. Epub 2010 Nov 11. No abstract available.

PMID:
21074406
33.

Radiopeptide internalisation and externalization assays: cell viability and radioligand integrity.

Naqvi SA, Sosabowski JK, Nagra SA, Ishfaq MM, Mather SJ, Matzow T.

Appl Radiat Isot. 2011 Jan;69(1):68-74. doi: 10.1016/j.apradiso.2010.09.005. Epub 2010 Sep 15.

PMID:
20880713
34.

High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.

Saha A, Ellison D, Thomas GJ, Vallath S, Mather SJ, Hart IR, Marshall JF.

J Pathol. 2010 Sep;222(1):52-63. doi: 10.1002/path.2745.

PMID:
20629113
35.

Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging.

Hong SY, Tobias G, Al-Jamal KT, Ballesteros B, Ali-Boucetta H, Lozano-Perez S, Nellist PD, Sim RB, Finucane C, Mather SJ, Green ML, Kostarelos K, Davis BG.

Nat Mater. 2010 Jun;9(6):485-90. doi: 10.1038/nmat2766. Epub 2010 May 16.

PMID:
20473287
36.

Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods.

Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA.

Chem Rev. 2010 May 12;110(5):3112-45. doi: 10.1021/cr900351r. Review. No abstract available.

PMID:
20415479
37.

188Re(CO)3-dipicolylamine-alendronate: a new bisphosphonate conjugate for the radiotherapy of bone metastases.

Torres Martin de Rosales R, Finucane C, Foster J, Mather SJ, Blower PJ.

Bioconjug Chem. 2010 May 19;21(5):811-5. doi: 10.1021/bc100071k.

PMID:
20387897
38.

Insertion of a lysosomal enzyme cleavage site into the sequence of a radiolabeled neuropeptide influences cell trafficking in vitro and in vivo.

Naqvi SA, Matzow T, Finucane C, Nagra SA, Ishfaq MM, Mather SJ, Sosabowski J.

Cancer Biother Radiopharm. 2010 Feb;25(1):89-95. doi: 10.1089/cbr.2009.0666.

PMID:
20187801
39.

The qualified person in radiopharmacy.

Mather SJ, Maltby P, Ellis B, O'Docherty M, Lewington V, Nunan T, Khan S, Hodges N.

Nucl Med Commun. 2010 Mar;31(3):187-9. doi: 10.1097/MNM.0b013e328334be8c. No abstract available.

PMID:
20124798
40.

Comments on the 'Implications of the Human Tissue Act (2004) on tissue storage for UK plastic surgeons' editorial published in the Journal of Plastic, Reconstructive & Aesthetic Surgery (2009) 62, 983-985.

Mather S.

J Plast Reconstr Aesthet Surg. 2010 Mar;63(3):568-70. doi: 10.1016/j.bjps.2009.11.053. Epub 2010 Jan 15. No abstract available.

PMID:
20079700
41.

Automated radiolabelling of monoclonal antibodies with the Modular Lab system.

Ellison D, Kaufman J, Mather SJ.

Nucl Med Commun. 2010 Feb;31(2):173-7. doi: 10.1097/MNM.0b013e3283348771.

PMID:
19952855
42.

Synthesis and optimization of the labeling procedure of 99mTc-HYNIC-interleukin-2 for in vivo imaging of activated T lymphocytes.

D'Alessandria C, di Gialleonardo V, Chianelli M, Mather SJ, de Vries EF, Scopinaro F, Dierck RA, Signore A.

Mol Imaging Biol. 2010 Oct;12(5):539-46. doi: 10.1007/s11307-009-0285-1. Epub 2009 Dec 1.

43.

Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide.

Sosabowski JK, Matzow T, Foster JM, Finucane C, Ellison D, Watson SA, Mather SJ.

J Nucl Med. 2009 Dec;50(12):2082-9. doi: 10.2967/jnumed.109.064808. Epub 2009 Nov 12.

44.

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo.

Rennel ES, Varey AH, Churchill AJ, Wheatley ER, Stewart L, Mather S, Bates DO, Harper SJ.

Br J Cancer. 2009 Oct 6;101(7):1183-93. doi: 10.1038/sj.bjc.6605249. Epub 2009 Aug 25.

45.

Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases.

Torres Martin de Rosales R, Finucane C, Mather SJ, Blower PJ.

Chem Commun (Camb). 2009 Aug 28;(32):4847-9. doi: 10.1039/b908652h. Epub 2009 Jul 14.

PMID:
19652801
46.

Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

von Guggenberg E, Sallegger W, Helbok A, Ocak M, King R, Mather SJ, Decristoforo C.

J Med Chem. 2009 Aug 13;52(15):4786-93. doi: 10.1021/jm900400w.

PMID:
19591486
47.

A novel model for the pre-clinical imaging of inflamed human synovial vasculature.

Garrood T, Blades M, Haskard DO, Mather S, Pitzalis C.

Rheumatology (Oxford). 2009 Aug;48(8):926-31. doi: 10.1093/rheumatology/kep117. Epub 2009 Jun 2.

PMID:
19491304
48.

Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids.

Surfraz MB, King R, Mather SJ, Biagini S, Blower PJ.

J Inorg Biochem. 2009 Jul;103(7):971-7. doi: 10.1016/j.jinorgbio.2009.04.007. Epub 2009 May 3.

PMID:
19447500
49.

99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.

King R, Surfraz MB, Finucane C, Biagini SC, Blower PJ, Mather SJ.

J Nucl Med. 2009 Apr;50(4):591-8. doi: 10.2967/jnumed.108.058289. Epub 2009 Mar 16.

50.

Radiopharmaceutical clinical trials - dose is more than sieverts and becquerels.

Ballinger JR, Mather SJ, O'Doherty MJ.

Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1217-8. doi: 10.1007/s00259-009-1071-7. No abstract available.

PMID:
19288100

Supplemental Content

Loading ...
Support Center